The Department of Arrhythmology and Electrophysiology of the San Donato General Hospital is particularly committed to the following research lines:
- Clinical studies and development of innovative technologies and catheters for the mapping and catheter ablation of atrial fibrillation (AF) and supraventricular arrhythmias, in particular those associated with anomalous pathways.
- Clinical studies and development of innovative technologies and catheters for the mapping and ablation of the arrhythmogenic substrate of Brugada syndrome.
- Clinical studies and development of innovative technologies and catheters for the mapping and catheter ablation of malignant ventricular arrhythmias.
- Molecular genetic characterization of the main arrhythmogenic cardiopathies, with clinical studies for the genotype-phenotype correlation and functional studies of the mutations found.
- Research for new biomarkers for cardio-arrhythmic syndromes, in particular for Brugada syndrome.
- Study of arrhythmic predisposition in some frequent genetic syndromes (type 1 neurofibromatosis, Marfan syndrome, Noonan syndrome and Ehlers Danlos syndrome).
- Development of new technologies and electrocardiographic analysis for the study and non-invasive diagnosis of cardiac arrhythmias.
- Clinical studies and development of new technologies for the identification of the best cardiac stimulation strategies, including remote monitoring systems for implantable devices.